Literature DB >> 15797975

Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events.

A J Szalai1, G S Alarcón, J Calvo-Alén, S M A Toloza, M A McCrory, J C Edberg, G McGwin, H M Bastian, B J Fessler, L M Vilá, R P Kimberly, J D Reveille.   

Abstract

OBJECTIVES: To determine if a polymorphic GTn repeat in the intron of the C-reactive protein (CRP) gene associates with occurrence of vascular arterial events in systemic lupus erythematosus (SLE).
METHODS: We performed a nested case-control study on the LUMINA cohort of 546 Hispanic, African-American and Caucasian SLE patients. Twenty-five patients who developed vascular arterial events (i.e. myocardial infarction, angina, coronary artery bypass graft surgery, stroke, claudication, gangrene or significant tissue loss and/or arterial peripheral thrombosis) after enrolment were selected as cases and 32 ethnically matched patients with no previous vascular arterial events served as controls. Their CRP gene GTn polymorphism and plasma CRP was determined.
RESULTS: Patients with vascular events had more severe SLE and were more likely to have plasma CRP in the highest quintile of measured values. The overall distribution of GTn alleles for patients with vascular events had a greater number of the GT20 variant compared with controls [26.0% of alleles (13/50) vs 15.6% (10/64)]. This greater number of GT20 in patients with vascular events was observed for African-Americans [29.2% (7/24) vs 21.0% (8/38)] and Hispanics [33.0% (4/12) vs 0% (0/16)] but not for Caucasians [14.3% (2/14) vs 20.0% (2/10)]. For African-Americans and Hispanics combined (45 patients), the frequency of GT20 in those with vascular events (30.6%, 11/36) was significantly higher than in those without them (14.8%, 8/54) (P<0.05, one-tailed test for difference in proportions). When patients were categorized according to the number of GT20 alleles they carried (thus GT20/GT20, GT20/GTx or GTx/GTx, where x is any allele other than GT20), for both African-Americans and Hispanics the likelihood of vascular arterial events increased in proportion with the GT20 dose, and all GT20-homozygous patients developed vascular arterial events.
CONCLUSIONS: The CRP GT20 variant is more likely to occur in African-American and Hispanic SLE patients than in Caucasian ones, and SLE patients carrying the GT20 allele are more likely to develop vascular arterial events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797975     DOI: 10.1093/rheumatology/keh613

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  18 in total

1.  Frequency of established cardiovascular disease and its risk factors in Chinese patients with systemic lupus erythematosus.

Authors:  Xiao-Yang Wang; Xue-Qing Tang; Ya-Juan Huang; Wei-Ying Chen; Xue-Qing Yu
Journal:  Clin Rheumatol       Date:  2011-12-23       Impact factor: 2.980

Review 2.  C-reactive protein in rheumatology: biology and genetics.

Authors:  Benjamin Rhodes; Barbara G Fürnrohr; Timothy J Vyse
Journal:  Nat Rev Rheumatol       Date:  2011-04-05       Impact factor: 20.543

3.  Management of cardiovascular complications in systemic lupus erythematosus.

Authors:  Carly Skamra; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

Review 4.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

5.  C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population.

Authors:  Yemil Atisha-Fregoso; Guadalupe Lima; Eduardo Carrillo-Maravilla; Rosalinda Posadas-Sánchez; Nonanzit Pérez-Hernández; Miguel Baños-Peláez; Alejandra Iturralde-Chávez; Nora Hernández-Díaz; Juan Jakez-Ocampo; José Manuel Rodríguez-Pérez; Gilberto Vargas-Alarcón; Luis Llorente; Juanita Romero-Díaz
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

6.  A national study of the complications of lupus in pregnancy.

Authors:  Megan E B Clowse; Margaret Jamison; Evan Myers; Andra H James
Journal:  Am J Obstet Gynecol       Date:  2008-05-05       Impact factor: 8.661

7.  Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort.

Authors:  A M Bertoli; L M Vilá; G S Alarcón; G McGwin; J C Edberg; M Petri; R Ramsey-Goldman; J D Reveille; R P Kimberly
Journal:  Lupus       Date:  2009-10       Impact factor: 2.911

Review 8.  Genetic determinants of C-reactive protein.

Authors:  Jacqueline Suk Danik; Paul M Ridker
Journal:  Curr Atheroscler Rep       Date:  2007-09       Impact factor: 5.113

9.  C-reactive protein gene and Toll-like receptor 4 gene polymorphisms can relate to the development of psoriatic arthritis.

Authors:  Ayla Akbal; Sevilay Oğuz; Ferhat Gökmen; Serhat Bilim; Hatice Reşorlu; Fatma Sılan; Ahmet Uludağ
Journal:  Clin Rheumatol       Date:  2014-04-03       Impact factor: 2.980

10.  Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.

Authors:  Eric J Brunner; Mika Kivimäki; Daniel R Witte; Debbie A Lawlor; George Davey Smith; Jackie A Cooper; Michelle Miller; Gordon D O Lowe; Ann Rumley; Juan P Casas; Tina Shah; Steve E Humphries; Aroon D Hingorani; Michael G Marmot; Nicholas J Timpson; Meena Kumari
Journal:  PLoS Med       Date:  2008-08-12       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.